E2C(R2)

Periodic Benefit-Risk Evaluation Report (PBRER / ICH E2C(R2))

Draft and validate the Periodic Benefit-Risk Evaluation Report per ICH E2C(R2). Integrates cumulative safety and efficacy data for an authorised medicinal product, producing a benefit-risk evaluation for regulatory submission to EMA, FDA (PADER), and other authorities.